Telle-Hansen, Vibeke H.
Gaundal, Line
Bastani, Nasser
Rud, Ida
Byfuglien, Marte G.
Gjøvaag, Terje
Retterstøl, Kjetil
Holven, Kirsten B.
Ulven, Stine M.
Myhrstad, Mari C. W.
Funding for this research was provided by:
Oslo Metropolitan University
University of Oslo
Mills AS
Article History
Received: 28 June 2022
Accepted: 12 September 2022
First Online: 26 September 2022
Declarations
:
: The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Regional Committees for Medical and Health Research Ethics (2018/104). Written informed consent was obtained from all subjects. The study was registered at Clinical Trials (ExternalRef removed, registration identification number: NCT03658681).
: Not applicable.
: LG, NB, TG and IR report nothing to declare. VHTH has been employed at Mills AS and reports grants from Mills AS. She does not own any stocks in the company, and the work performed in this paper was done after she left the company. MGB is employed at Mills AS. She does not own any stocks in the company. She did not have a role in the design of the study and analysis of the data and was not involved in the statistical analysis. KR reports personal fees from MedXplore, Amgen, Mills AS, The Norwegian Medical Association, The Norwegian Directorate of Health, Sanofi, Takeda, Chiesi, Bayer and MSD, outside the submitted work. KBH reports grants from Tine SA, Mills AS, Olympic Seafood, Amgen, Sanofi, Kaneka and personal fees from Amgen, Sanofi, Pronova, outside the submitted work. SMU has received research grants from Tine DA, Mills AS, and Olympic Seafood, none of which are related to the content of this manuscript. MCWM is involved in projects with research grants from Tine SA and Olympic Seafood and has received research funds from Mills AS, none of which are related to the content of this manuscript.